Maintenance intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: trends from an Australian tertiary centre
Treatment Efficacy Intravenous immunoglobulin (IVIG) has emerged as a cornerstone therapeutic option for patients suffering from chronic inflammatory demyelinating polyneuropathy […]
